Chronic Urinary Retention in Elderly Living in Homes for the Aged : Benefits of Bladder Scan Screening (RUC EHPAD)

April 11, 2023 updated by: Rennes University Hospital
The goal of this cross-sectional, multicentric and descriptive epidemiological study is to assess the prevalence of chronic urinary retention (CUR) in elderly living in residential care for dependent elderly people in order to determine if there is an interest in offering them a bladder scan screening.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The main goal of this study is to assess the prevalence of CUR in elderly living in homes for the aged, the secondary ones are to evaluate the risk factors and complications of CUR.

We will carry out this prevalence study in 5 centres whit a draw of 40 residents per centre. Following an information and a non-opposition of the patients, we will collect datas in their medical file (age, medical history and comorbidities, current treatments, anticholinergic score according to the ADS (Anticholinergic Drug Scale), GIR score according to the AGGIR scale (Autonomie Gérontologique Groupes Iso Ressources), FAC modified score (Functional Ambulation Classification modified), MMSE score (Mini Mental State Examination), communicative capacity, notion of fall and date of last fall, knowledge of urinary incontinence, knowledge of constipation, knowledge of previous urinary screening by bladder scan and previous urological consulting, last urinalysis and its results, last analysis of creatinemia and creatinine clearance according to CKD-EPI) and we will perform up to 3 measurements of vesical volume by bladder scan.

The expected results are a prevalence of CUR between 10 and 20 % among people living in homes for the aged with more urinary tract infections, renal insufficiency and falls in the CUR group showing the interest of screening for CUR by bladder scan in elderly people living in nursing homes according to risk groups based on the risk factors found.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Direction de la Recherche
  • Phone Number: 33 2 99 28 25 55
  • Email: drc@chu-rennes.fr

Study Locations

      • Combourg, France, 35270
        • EHPAD du Centre Local Hospitalier de Saint-Joseph
        • Contact:
          • Karine BREGAIN, MD
          • Phone Number: 2 99 73 05 34
        • Principal Investigator:
          • Karine BREGAIN, MD
      • Fougères, France, 35300
        • EHPAD du Centre Hospitalier de Fougères
        • Contact:
          • Didier MARCHAND, MD
          • Phone Number: 33 2 99 17 70 90
        • Principal Investigator:
          • Didier MARCHAND, MD
      • Rennes, France, 35000
        • EHPAD Hôtel-Dieu
        • Contact:
        • Principal Investigator:
          • Frederique BRILLANT, MD
      • Saint-Brice-en-Coglès, France, 35460
        • EHPAD de Saint-Brice-en-Coglès
        • Contact:
          • Mohammed BRAHIMI, MD
          • Phone Number: 33 2 99 98 68 00
        • Principal Investigator:
          • Mohammed BRAHIMI, MD
      • Saint-Georges-de-Reintembault, France, 35420
        • EHPAD de Saint-Georges-de-Reintembault
        • Principal Investigator:
          • Mohammed BRAHIMI, MD
        • Contact:
          • Mohammed BRAHIMI
          • Phone Number: 33 2 99 97 03 10

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult people
  • Residents in a participating nursing home

Exclusion Criteria:

  • Resident with indwelling urinary catheter or regular urinary catheterisation
  • Resident or legal representative opposing participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Bladder scan
Bladder scan performed on resident in homes for aged
Measurement of vesical volume by bladder scan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic urinary retention
Time Frame: 4 weeks after inclusion
Chronic urinary retention definition : post-void residual urine > 250 mL twice without any clinical argument for acute urinary retention.
4 weeks after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thibaud HONORE, MD, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2019

Primary Completion (Actual)

May 17, 2019

Study Completion (Actual)

May 17, 2019

Study Registration Dates

First Submitted

January 31, 2019

First Submitted That Met QC Criteria

February 1, 2019

First Posted (Actual)

February 4, 2019

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 35RC18_3063_RUC EHPAD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Retention

Clinical Trials on bladder scan

3
Subscribe